Juno Therapeutics, Inc., A Bristol-myers Squibb Company

This study aimed to test a new cell therapy called Liso-cel against standard treatments for adults with follicular lymphoma that returned or didn't respond to prior therapy. The trial was withdrawn before enrolling any participants, so no results are available. The goal was to se…